Stock Events

Stock Events

Atea Pharmaceuticals (AVIR) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.75

-0.62

-0.5

-0.37

Details

Expected EPS

-0.4267

Actual EPS

-0.37

Surprise EPS

0.06

Surprise Percent

+13.29%

Description

Atea Pharmaceuticals (AVIR) has reported earnings of -0.37 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.